Details of Disease

General Information of Disease (ID: DIS5CMI0)

• Disease Name: Lung infection
• Disease Class: CA4Z: Lung infection
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DIS5CMI0: Lung infection
• ICD Code:
  ICD-11: ICD-11: CA4Z
  ICD-9: ICD-9: 162
  Expand ICD-11: 'CA4Z
  Expand ICD-10: 'J09-J18; 'J20-J22; 'J22
  Expand ICD-9: 162

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Cipro Inhale	DM5X6W0	Phase 3	Small molecular drug	[1]
Carlecortemcel-L	DM87P0F	Phase 2/3	NA	[2]

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Panaecin	DM8UV1F	Investigative	NA	[3]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022002)
• [2] ClinicalTrials.gov (NCT00469729) Efficacy and Safety Study of StemEx, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy. U.S. National Institutes of Health.
• [3] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.